PTEN, as a negative regulator of the PI3K-AKT pathway [105], is regulated mainly by single allele-deletion, which was significantly increased in imatinib-resistant GIST patients compared with imatinib-sensitive GISTs patients (39% vs. 9%) [106]. Here, AKT1 is linked to gastrointestinal stromal tumor.